Integration of adeno-associated virus-derived peptides into nonviral vectors to synergistically enhance cellular transfection

Jung Suk Kim, Eunmi Kim, Ji Seon Oh, Jae-Hyung Jang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

This study describes a simple, versatile approach for developing a nonviral gene carrier by adopting the highly efficient gene delivery properties of the adeno-associated virus (AAV). Specific viral peptides (r3.45-hepBD) extracted from AAV r3.45, which directly evolved to improve gene delivery capabilities in many cell types, were conjugated onto branched polyethylenimine (PEI) to form hybrid gene carriers. AAV r3.45 carries a sequence insertion (LATQVGQKTA; r3.45) within the heparin-binding domain (LQRGNRQA; hepBD), which ultimately comprises a novel sequence (LQRGNLATQVGQKTARQA; r3.45-hepBD) on the capsid. This sequence is hypothesized to be a crucial cue to enhance gene delivery efficiency. Consequently, the intimate interactions of the conjugated r3.45-hepBD with the glycosaminoglycans, including chondroitin sulfate, resulted in significantly enhanced cellular transfection of DNA/PEI-r3.45-hepBD complexes. The successful establishment of a nonviral system that is built with novel peptides will provide a powerful means for developing a substantial number of gene therapy applications.

Original languageEnglish
Pages (from-to)2136-2145
Number of pages10
JournalBiomacromolecules
Volume14
Issue number7
DOIs
Publication statusPublished - 2013 Jul 8

Fingerprint

Viruses
Peptides
Genes
Polyethyleneimine
Gene therapy
Chondroitin Sulfates
Glycosaminoglycans
Heparin
DNA

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Materials Chemistry
  • Polymers and Plastics
  • Biomaterials

Cite this

@article{897b6f3c09834ca0ae73ea9a1fecaf8d,
title = "Integration of adeno-associated virus-derived peptides into nonviral vectors to synergistically enhance cellular transfection",
abstract = "This study describes a simple, versatile approach for developing a nonviral gene carrier by adopting the highly efficient gene delivery properties of the adeno-associated virus (AAV). Specific viral peptides (r3.45-hepBD) extracted from AAV r3.45, which directly evolved to improve gene delivery capabilities in many cell types, were conjugated onto branched polyethylenimine (PEI) to form hybrid gene carriers. AAV r3.45 carries a sequence insertion (LATQVGQKTA; r3.45) within the heparin-binding domain (LQRGNRQA; hepBD), which ultimately comprises a novel sequence (LQRGNLATQVGQKTARQA; r3.45-hepBD) on the capsid. This sequence is hypothesized to be a crucial cue to enhance gene delivery efficiency. Consequently, the intimate interactions of the conjugated r3.45-hepBD with the glycosaminoglycans, including chondroitin sulfate, resulted in significantly enhanced cellular transfection of DNA/PEI-r3.45-hepBD complexes. The successful establishment of a nonviral system that is built with novel peptides will provide a powerful means for developing a substantial number of gene therapy applications.",
author = "Kim, {Jung Suk} and Eunmi Kim and Oh, {Ji Seon} and Jae-Hyung Jang",
year = "2013",
month = "7",
day = "8",
doi = "10.1021/bm4005854",
language = "English",
volume = "14",
pages = "2136--2145",
journal = "Biomacromolecules",
issn = "1525-7797",
publisher = "American Chemical Society",
number = "7",

}

Integration of adeno-associated virus-derived peptides into nonviral vectors to synergistically enhance cellular transfection. / Kim, Jung Suk; Kim, Eunmi; Oh, Ji Seon; Jang, Jae-Hyung.

In: Biomacromolecules, Vol. 14, No. 7, 08.07.2013, p. 2136-2145.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Integration of adeno-associated virus-derived peptides into nonviral vectors to synergistically enhance cellular transfection

AU - Kim, Jung Suk

AU - Kim, Eunmi

AU - Oh, Ji Seon

AU - Jang, Jae-Hyung

PY - 2013/7/8

Y1 - 2013/7/8

N2 - This study describes a simple, versatile approach for developing a nonviral gene carrier by adopting the highly efficient gene delivery properties of the adeno-associated virus (AAV). Specific viral peptides (r3.45-hepBD) extracted from AAV r3.45, which directly evolved to improve gene delivery capabilities in many cell types, were conjugated onto branched polyethylenimine (PEI) to form hybrid gene carriers. AAV r3.45 carries a sequence insertion (LATQVGQKTA; r3.45) within the heparin-binding domain (LQRGNRQA; hepBD), which ultimately comprises a novel sequence (LQRGNLATQVGQKTARQA; r3.45-hepBD) on the capsid. This sequence is hypothesized to be a crucial cue to enhance gene delivery efficiency. Consequently, the intimate interactions of the conjugated r3.45-hepBD with the glycosaminoglycans, including chondroitin sulfate, resulted in significantly enhanced cellular transfection of DNA/PEI-r3.45-hepBD complexes. The successful establishment of a nonviral system that is built with novel peptides will provide a powerful means for developing a substantial number of gene therapy applications.

AB - This study describes a simple, versatile approach for developing a nonviral gene carrier by adopting the highly efficient gene delivery properties of the adeno-associated virus (AAV). Specific viral peptides (r3.45-hepBD) extracted from AAV r3.45, which directly evolved to improve gene delivery capabilities in many cell types, were conjugated onto branched polyethylenimine (PEI) to form hybrid gene carriers. AAV r3.45 carries a sequence insertion (LATQVGQKTA; r3.45) within the heparin-binding domain (LQRGNRQA; hepBD), which ultimately comprises a novel sequence (LQRGNLATQVGQKTARQA; r3.45-hepBD) on the capsid. This sequence is hypothesized to be a crucial cue to enhance gene delivery efficiency. Consequently, the intimate interactions of the conjugated r3.45-hepBD with the glycosaminoglycans, including chondroitin sulfate, resulted in significantly enhanced cellular transfection of DNA/PEI-r3.45-hepBD complexes. The successful establishment of a nonviral system that is built with novel peptides will provide a powerful means for developing a substantial number of gene therapy applications.

UR - http://www.scopus.com/inward/record.url?scp=84880077542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880077542&partnerID=8YFLogxK

U2 - 10.1021/bm4005854

DO - 10.1021/bm4005854

M3 - Article

C2 - 23701437

AN - SCOPUS:84880077542

VL - 14

SP - 2136

EP - 2145

JO - Biomacromolecules

JF - Biomacromolecules

SN - 1525-7797

IS - 7

ER -